Key Financial’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.2K Hold
200
– – ﹤0.01% 803
2026
Q2
$17K Hold
200
– – ﹤0.01% 755
2026
Q1
$13.2K Hold
200
– – ﹤0.01% 819
2025
Q4
$12.7K Buy
+200
New +$12.4K ﹤0.01% 818

Other funds holding CYTK

Key Financial's CYTK Position: Q3 2026 in Review

Key Financial held its Cytokinetics (CYTK) position steady in Q3 2026 at 200 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #803.

Key Financial first reported a position in CYTK in Q4 2025 and has held it in 4 quarters since. The position peaked at $17K in Q2 2026. 348 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.

  • Key Financial held 200 shares of Cytokinetics worth $13.2K as of Q3 2026.
  • Key Financial left its Cytokinetics share count unchanged in Q3 2026.
  • Cytokinetics made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #803 holding.
  • Key Financial first reported a position in Cytokinetics in Q4 2025 and has held it in 4 quarters since.
  • Key Financial's Cytokinetics position peaked at $17K in Q2 2026.
  • 348 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.

Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.